Literature DB >> 3294836

Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation. Insulin is not required.

H Wallberg-Henriksson, N Zetan, J Henriksson.   

Abstract

The mechanisms by which insulin deficiency affects muscle glucose transport were investigated. Epitrochlearis muscles from rats with streptozotocin-induced diabetes and from controls were incubated in vitro for 0.5-14 h. The incubation was shown not to impair muscle energy stores or tissue oxygenation. Diabetes decreased basal 3-O-methylglucose transport by 40% (p less than 0.01), and insulin-stimulated (20 milli-units/ml) glucose transport capacity by 70% (p less than 0.001). In vitro incubation gradually normalized insulin responsiveness (3.77 +/- 0.38 before versus 8.97 +/- 0.65 mumol X ml-1 X h-1 after 12 h of incubation). Basal glucose transport remained significantly reduced. The reversal of the insulin responsiveness did not require the presence of rat serum and, furthermore, took place even in the absence of insulin. In fact, insulin responsiveness was higher after incubation (14 h) with no insulin than with 100 microunits/ml insulin (9.85 +/- 0.59 versus 8.06 +/- 0.59 mumol X ml-1 X h-1, p less than 0.05). Glucose at 30 mM did not affect the normalization of the insulin-stimulated glucose transport capacity, whereas incubation in serum from diabetic rats resulted in a slightly (26%) blunted reversal (7.60 +/- 0.39 versus 8.89 +/- 0.45 mumol X ml-1 X h-1 with diabetic versus control serum for 14 h, p less than 0.05; before incubation the value was 3.87 +/- 0.40). Inhibition of protein synthesis by cycloheximide blocked the normalization by 80%. These results suggest the presence in diabetic serum of some labile factor that might inhibit the glucose transport system. The results indicate that the decreased insulin-stimulated glucose transport capacity, in the insulin-deficient diabetic muscle, is not a direct consequence of the lack of insulin or of high glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3294836

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2.

Authors:  A V Chibalin; M Yu; J W Ryder; X M Song; D Galuska; A Krook; H Wallberg-Henriksson; J R Zierath
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle.

Authors:  D Dimitrakoudis; T Ramlal; S Rastogi; M Vranic; A Klip
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 3.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.

Authors:  B B Kahn
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle.

Authors:  J W Ryder; Y Kawano; A V Chibalin; J Rincón; T S Tsao; A E Stenbit; T Combatsiaris; J Yang; G D Holman; M J Charron; J R Zierath
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

5.  C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation.

Authors:  J R Zierath; A Handberg; M Tally; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 6.  Insulin action in skeletal muscle from patients with NIDDM.

Authors:  J R Zierath; A Krook; H Wallberg-Henriksson
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

Authors:  J R Zierath; L He; A Gumà; E Odegoard Wahlström; A Klip; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

8.  Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips.

Authors:  J R Zierath; D Galuska; A Engström; K H Johnson; C Betsholtz; P Westermark; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

9.  Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.

Authors:  J R Zierath; D Galuska; L A Nolte; A Thörne; J S Kristensen; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

10.  Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle.

Authors:  J R Zierath; D Galuska; B L Johansson; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.